Hemab Therapeutics vs ElevenLabs

Side-by-side comparison of AI visibility scores, market position, and capabilities

ElevenLabs leads in AI visibility (84 vs 22)
Hemab Therapeutics logo

Hemab Therapeutics

EmergingBioTech

Rare Bleeding Disorders

Raised $157M oversubscribed Series C (Oct 2025) led by Sofinnova and Qatar Investment Authority. Sutacimig entering registration study 2026 for Glanzmann thrombasthenia — zero approved prophylactics.

AI VisibilityBeta
Overall Score
D22
Category Rank
#1 of 1
AI Consensus
66%
Trend
up
Per Platform
ChatGPT
26
Perplexity
33
Gemini
31

About

Hemab Therapeutics is a rare disease biotechnology company developing treatments for rare bleeding disorders that have no approved prophylactic options. The company raised $157 million in an oversubscribed Series C in October 2025, led by Sofinnova Partners and the Qatar Investment Authority (QIA) — a sovereign wealth fund's direct biotech investment signals strategic medical technology interest alongside financial return.

Full profile
ElevenLabs logo

ElevenLabs

ChallengerAI & Machine Learning

Voice AI

$500M Series D at $11B valuation (Feb 2026) — largest voice AI funding round ever. $330M ARR; 1M+ developers using the API. Enterprise customers: Deutsche Telekom, Revolut, Meta, Salesforce. Voices in 32 languages; real-time cloning from 1 second of audio.

AI VisibilityBeta
Overall Score
A84
Category Rank
#1 of 1
AI Consensus
64%
Trend
up
Per Platform
ChatGPT
79
Perplexity
89
Gemini
82

About

ElevenLabs was founded in 2022 by Piotr Dabkowski and Mati Staniszewski, two former Google and Palantir engineers who set out to break the language barrier using AI voice technology. The company specializes in AI-powered voice synthesis, cloning, and dubbing, enabling developers and enterprises to generate human-quality speech in over 30 languages. Its core technology combines deep learning models trained on massive speech datasets to produce natural-sounding voices indistinguishable from real humans.\n\nElevenLabs offers a suite of products including its flagship text-to-speech API, voice cloning tools, and an AI dubbing platform that localizes video content while preserving the speaker's original voice. Its products target a broad audience—from indie developers building audio apps to large enterprises deploying voice interfaces at scale. Key differentiators include ultra-low latency streaming synthesis, fine-grained voice customization, and a growing library of pre-built AI voices across accents and styles.\n\nElevenLabs has grown rapidly, surpassing $330M in annualized revenue and serving over 1 million developers. Enterprise clients include Deutsche Telekom, Spotify, and leading media companies. In February 2026, the company closed a $500M Series D at an $11B valuation, cementing its position as the market leader in AI voice. Its APIs power podcasts, audiobooks, video games, and customer service bots worldwide, making ElevenLabs the default infrastructure layer for AI-generated audio.

Full profile

AI Visibility Head-to-Head

22
Overall Score
84
#1
Category Rank
#1
66
AI Consensus
64
up
Trend
up
26
ChatGPT
79
33
Perplexity
89
31
Gemini
82
21
Claude
75
21
Grok
88

Capabilities & Ecosystem

Capabilities

Only Hemab Therapeutics
Rare Bleeding Disorders
Only ElevenLabs
Voice AI

Integrations

Only ElevenLabs

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.